Rick Gussio Selected Research

Rick Gussio Research Topics

Disease

6	Neoplasms (Cancer) 11/2018 - 08/2005
4	Botulism 05/2015 - 06/2010
3	Anthrax 05/2009 - 10/2005
2	Poisoning 01/2015 - 10/2010
1	Glioblastoma (Glioblastoma Multiforme) 11/2018
1	Rupture 08/2013
1	Paralysis (Palsy) 07/2012
1	Infections 10/2009
1	Coffin-Lowry Syndrome (Syndrome, Coffin-Lowry) 09/2006
1	Carcinoma (Carcinomatosis) 04/2002
1	Carcinogenesis 04/2002

Drug/Important Bio-Agent (IBA)

3	Botulinum Toxins (Botulinum Toxin)IBA 05/2015 - 06/2010
2	anthrax toxin (anthrax lethal factor)IBA 08/2013 - 10/2005
2	Metalloproteases (Metalloproteinases)IBA 07/2012 - 10/2010
2	EnzymesIBA 10/2010 - 04/2002
1	CarbazolesIBA 11/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015
1	Lipid Bilayers (Lipid Bilayer)IBA 08/2013
1	TubulinIBA 05/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012
1	furanIBA 05/2012
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2010
1	ZincIBA 10/2010
1	Colchicine FDA LinkGeneric 07/2010
1	Peptide Hydrolases (Proteases)FDA Link 06/2010
1	incobotulinumtoxinA FDA Link 06/2010
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2009
1	Protein Tyrosine PhosphatasesIBA 05/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2007
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2006
1	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2006
1	Adenosine Triphosphate (ATP)IBA 09/2006
1	Phosphotransferases (Kinase)IBA 09/2006
1	edema factorIBA 10/2005
1	Ion Channels (Ion Channel)IBA 10/2005
1	AntigensIBA 10/2005
1	Monoclonal AntibodiesIBA 10/2005
1	Proteins (Proteins, Gene)FDA Link 10/2005
1	epothilone AIBA 08/2005
1	FR 182877IBA 08/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2005
1	2,3- bis(2- hydroxyethylsulfanyl)- (1,4)naphthoquinoneIBA 04/2002
1	Dual-Specificity PhosphatasesIBA 04/2002

Therapy/Procedure

6	Therapeutics 11/2018 - 10/2005